Drugs / Tenofovir Disproxil Fumrarate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00384904 | Dec 2006 → Dec 2007 | HIV infectious disease | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenofovir Disproxil Fumrarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00384904 ↗ |
| Route | Oral | “Capsules/capsules + Tablets + Tablets, Oral, 300/100 mg + 300 mg + 40 mg, Once daily + Twice daily, 7 days.” NCT00384904 ↗ |